Method for treatment with bucindolol based on genetic targeting

Details for Australian Patent Application No. 2005284822 (hide)

Owner Regents of the University of Colorado

Inventors Liggett, Stephen B.; Bristow, Michael

Agent Pizzeys

Pub. Number AU-B-2005284822

PCT Pub. Number WO2006/031955

Priority 60/610,706 17.09.04 US; 60/609,689 14.09.04 US

Filing date 14 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 24 March 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/031955 Priority application(s): WO2006/031955

3 April 2008 Assignment before Grant

  The Regents of the University of Colorado, a Body Corporate; The University of Cincinnati The application has been assigned to Regents of the University of Colorado

24 March 2011 Application Accepted

  Published as AU-B-2005284822

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005284825-Self-sealing male Luer connector with molded elastomeric tip

2005284816-Systems for managing electrical power